Menu Search
Equities

Sanara Medtech Inc

SMTI:NAQ

Sanara Medtech Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)37.95
  • Today's Change0.626 / 1.68%
  • Shares traded33.57k
  • 1 Year change+17.05%
  • Beta1.5846
Data delayed at least 15 minutes, as of Nov 22 2024 20:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sanara Medtech Inc grew revenues 41.77% from 45.84m to 64.99m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -7.94m to -4.30m.
Gross margin90.16%
Net profit margin-10.86%
Operating margin-8.41%
Return on assets-10.33%
Return on equity-19.89%
Return on investment-12.37%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Sanara Medtech Inc fell by 3.81m. Cash Flow from Financing totalled 9.64m or 14.83% of revenues. In addition the company used 3.25m for operations while cash used for investing totalled 10.21m.
Cash flow per share-0.4811
Price/Cash flow per share--
Book value per share4.55
Tangible book value per share-0.6688
More ▼

Balance sheet in USDView more

Sanara Medtech Inc has a Debt to Total Capital ratio of 43.26%, a higher figure than the previous year's 21.34%.
Current ratio2.23
Quick ratio2.02
Total debt/total equity0.756
Total debt/total capital0.4326
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.